Please login to the form below

Not currently logged in
Email:
Password:

Latin American

This page shows the latest Latin American news and features for those working in and with pharma, biotech and healthcare.

Ariad files early marketing application for brigatinib

Ariad files early marketing application for brigatinib

On Friday, the company announced it had licensed Latin American distribution rights to Pint Pharma International and Middle East/North Africa rights Biologix FZCo.

Latest news

More from news
Approximately 1 fully matching, plus 25 partially matching documents found.

Latest Intelligence

  • Focusing on value Focusing on value

    The food supplement for gastro-intestinal problems was launched in January in Chile, as part of its Latin American roll-out. ... A second wave came with the shift of Vigantol in 2015, and earlier this year a third wave of transfers began in Latin America,

  • The pill branding The pill branding

    Next Choice”. Desperation in India, Iran and Kenya. Negative messages prevail in the analysed Asian, African and Latin American markets (eg Unwanted, PregNon, Ovocease, Preventol, Escapelle). ... In Eastern Europe and Belarus, the positioning rather

  • Clinical trial regulation in Mexico Clinical trial regulation in Mexico

    This timeline is similar to that in European countries and much better than those normally seen in other Latin American countries that are often considered as important clinical trial outsourcing destinations. ... own. In terms of sales, Mexico is the

  • Current development and marketing of biosimilar monoclonal antibodies in Latin America Current development and marketing of biosimilar monoclonal antibodies in Latin America

    Latin American commercialisation partner. Rituximab. Dr. Reddy's. India. Reditux / Tidecron. ... Miguel is a regional consultant - Iberia and LatAm, Areli is an associate, Gabriel is consultant and Patrick is a partner and head of EMEA and Latin America.

  • Unfolding the biosimilar landscape in Latin America Unfolding the biosimilar landscape in Latin America

    The Latin American biosimilar regulatory landscape: very diverse but collectively gravitating towards an increased quality bar. ... The regulatory landscape is not the only difference across different Latin American countries.

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

  • Alexion appoints new senior VP for EMEAC region Alexion appoints new senior VP for EMEAC region

    She was most recently president, international markets at Glenmark Pharmaceuticals, where she led the commercial organisation across the European, Russian, Asian and Latin American regions.

  • Oscar Ferenczi joins Grünenthal from Sandoz Oscar Ferenczi joins Grünenthal from Sandoz

    Oscar Ferenczi joins Grünenthal from Sandoz. Will lead German pharma company's Latin American expansion plans. ... Grünenthal has appointed former region head of Sandoz Latin America Oscar Ferenczi to lead its own Latin America business.

  • Icon boosts Asia Pacific and Latin American leadership

    Icon boosts Asia Pacific and Latin American leadership. Appoints Wei Ming Goh and Dr Dennis Hurley as regional VPs. ... I'm very pleased to welcome Wei Ming and Dennis to Icon's Latin American and Asia Pacific leadership teams.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Exploring MINT: Part 1 - Mexico

    speaking Latin American markets. ... COFEPRIS is particularly important from a regional perspective as it is extending its role to the harmonization of regulation with other Latin American markets.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics